Dr. Timothy A Alexander, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 9000 Ne 2nd Ave, Miami Shores, FL 33138 Phone: 954-565-7575 Fax: 954-564-1725 |
Dr. Onyeka Nwokocha, M.D. Surgery Medicare: May Accept Medicare Assignments Practice Location: 9415 Ne 6th Ave, Miami Shores, FL 33138 Phone: 786-401-6455 Fax: 786-401-6394 |
Dr. John A. King, M.D. Surgery - Vascular Surgery Medicare: Medicare Enrolled Practice Location: 1300 Ne 103rd St, Miami Shores, FL 33138 Phone: 305-754-1087 Fax: 305-758-3632 |
Dr. David Clifton Llewellyn Phillibert, MD Surgery Medicare: Medicare Enrolled Practice Location: 9415 Ne 6th Ave, Miami Shores, FL 33138 Phone: 786-401-6455 |
Dr. Maurice David Lebowitz, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1285 Ne 102nd St, Miami Shores, FL 33138 Phone: 305-757-1255 Fax: 305-758-1140 |
Dr. Romane Joseph, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9415 Ne 6th Ave, Miami Shores, FL 33138 Phone: 786-401-6455 Fax: 786-401-6394 |
News Archive
Patients with knee osteoarthritis requiring analgesic therapy are often not receiving adequate pain relief, researchers report.
A dog's gait, according to the American Kennel Club, is "the pattern of footsteps at various rates of speed, each distinguished by a particular rhythm and footfall." When dogs trot, for example, the right front leg and the left hind leg move together. This is an intermediate gait, faster than walking but slower than running.
A team of researchers from the Laboratory of Biophysics at NUST MISIS, Lomonosov Moscow State University and D. Mendeleev University of Chemical Technology of Russia has summarized metal-containing diagnostic agents for positron emission tomography (PET), magnetic resonance imaging (MRI), and single-photon emission computed tomography (SPECT) imaging of Alzheimer's disease (AD).
Contraindicated antiplatelet use is rare but persists in patients undergoing percutaneous coronary intervention, show US study data.
Celldex Therapeutics, Inc. today announced that interim results from a Phase 2b study evaluating rindopepimut (formerly PF-04948568 or CDX-110) in newly-diagnosed glioblastoma multiforme (GBM) patients were presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
› Verified 3 days ago